Elias Obeid Joins Fox Chase’s Departments of Medical Oncology and Clinical Genetics
PHILADELPHIA, PA (October 25, 2013)—Elias Obeid, MD, MPH, has joined the departments of clinical genetics and medical oncology at Fox Chase Cancer Center. He specializes in breast and ovarian cancer risk assessment and in the treatment of patients with breast cancer.
Before joining Fox Chase, Dr. Obeid served as instructor in the department of medicine, section of hematology/oncology at the University of Chicago, where he also completed research fellowship training. In addition, he completed a clinical fellowship in hematology/oncology at the University of Chicago Medical Center.
Dr. Obeid received his medical degree from American University of Beirut School of Medicine and completed his residency in internal medicine at Yale-New Haven Medical Center, Saint Raphael Campus.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.